Santiago de Compostela

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
CHOP Plus Mosunetuzumab as First Line in Patients With Richter´s Syndrome: a Phase II Study of the Spanish Group of CLL	Richter transformation	Recruiting	Phase 2	2025-04-13		NCT06926205

Clinical trials